We are live on ! Find out more
AHCO icon

AdaptHealth

23 hedge funds and large institutions have $105M invested in AdaptHealth in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

5% more funds holding

Funds holding: 2223 (+1)

4% less capital invested

Capital invested by funds: $110M → $105M (-$4.48M)

1.24% less ownership

Funds ownership: 36.28%35.04% (-1.2%)

Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
5
Reduced
2
Closed
1
Calls
$2.46M
Puts
Net Calls
+$2.46M
Net Calls Change
+$2.09M

AHCO Hedge Fund Activity: Q4 2018 in Review

23 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q4 2018, worth a combined $105M — down 4.1% from $110M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new AHCO positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Tudor Investment Corp, opening a new position worth an estimated $4.9M. The largest seller was Basso Capital Management, exiting entirely with an estimated $8.19M sold.

  • 23 institutional investors held AdaptHealth (AHCO) as of Q4 2018, up from 22 in Q3 2018.
  • Funds reported $105M of AdaptHealth stock for Q4 2018, down 4.1% quarter-over-quarter.
  • 2 funds opened new AdaptHealth positions in Q4 2018 and 1 closed out, a net change of +1 holder.
  • The largest AdaptHealth buyer in Q4 2018 was Tudor Investment Corp, an estimated $4.9M added.
  • The largest AdaptHealth seller in Q4 2018 was Basso Capital Management, an estimated $8.19M sold.

Based on aggregated 13F filings for Q4 2018.